Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amarin Corp ADR (AMRN)

Amarin Corp ADR (AMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript

AMRN earnings call for the period ending December 31, 2023.

AMRN : 0.8908 (+0.18%)
Why Amarin Stock Skyrocketed Today

The biopharma company announced a big repurchase plan, along with strong preliminary Q4 results.

AMRN : 0.8908 (+0.18%)
Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript

AMRN earnings call for the period ending September 30, 2023.

AMRN : 0.8908 (+0.18%)
Why Amarin Stock Is Sinking Today

The drugmaker announced a major corporate reorganization and a new CEO.

AMRN : 0.8908 (+0.18%)
Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript

AMRN earnings call for the period ending March 31, 2023.

AMRN : 0.8908 (+0.18%)
Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall

Amarin's (AMRN) first-quarter 2023 earnings and revenues beat estimates. Vascepa sales decline.

AMRN : 0.8908 (+0.18%)
RCUS : 18.88 (+3.68%)
ALLO : 4.47 (+0.22%)
OCUP : 2.01 (-0.50%)
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More

Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.

UTHR : 229.72 (-5.57%)
PCRX : 29.22 (+0.62%)
AMRN : 0.8908 (+0.18%)
CORT : 25.19 (-0.51%)
IONS : 43.35 (-2.93%)
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

On CRISPR's (CRSP) first-quarter earnings call, investors will likely focus on its pipeline, especially its lead candidate exa-cel, due to the absence of marketed drugs.

VRTX : 418.01 (+0.17%)
AMRN : 0.8908 (+0.18%)
CRSP : 68.16 (-2.85%)
ALLO : 4.47 (+0.22%)
Perrigo (PRGO) to Report Q1 Earnings: What's in the Cards?

Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter.

PRGO : 32.19 (+2.32%)
AMRN : 0.8908 (+0.18%)
ARGX : 393.72 (-1.22%)
ALLO : 4.47 (+0.22%)
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

Higher sales of Zoetis' (ZTS) key drugs like Apoquel, Cytopoint, Simparica Trio, Librela and Solensia are likely to have driven first-quarter sales.

AMRN : 0.8908 (+0.18%)
ZTS : 169.21 (+0.42%)
RETA : 172.36 (+0.02%)
ALLO : 4.47 (+0.22%)

Barchart Exclusives

Ford Motor vs. Toyota: Which Hybrid EV Stock Is a Better Buy?
With hybrid EVs gaining popularity, let’s find out whether shares of Ford or Toyota are a better buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar